PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25041784-0	2014	HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer.	Anthracyclines	55-68	erb-b2 receptor tyrosine kinase 2	Homo sapiens	0-4	
25041784-8	2014	CONCLUSION: HER2 overexpression in primary tumors might be a predictive marker for good efficacy of anthracycline-based neoadjuvant chemotherapy.	Anthracyclines	100-113	erb-b2 receptor tyrosine kinase 2	Homo sapiens	12-16